+1 602 381 1091
by in Uncategorized

New HIN Authorized Licensee: A2A Integrated Logistics Inc & ModernaTX, Inc

To assist you in determining which of your trading partners are eligible to receive HIN data, HIBCC maintains a current full list of all Authorized HIN Licensees on our website. Authorized Licensees are prohibited from disclosing any information contained in the HIN Database to any other individual, association, firm, parent or subsidiary organization that is […]

by in Uncategorized

Register now for our HIBCC UDI Webinar

To register for the HIBCC UDI Webinar: FDA UDI Labeling and GUDID Submission Requirements click here. HIBCC is designated as an Issuing Entity by both the European Commission and the US FDA for their respective UDI initiatives. To learn more about HIBCC and UDI, visit www.hibcc.org or contact HIBCC directly at info@hibcc.org or +1 (602) 381-1091.

by in Uncategorized

New HIN Authorized Licensee: Genmab US, Inc.

To assist you in determining which of your trading partners are eligible to receive HIN data, HIBCC maintains a current full list of all Authorized HIN Licensees on our website. Authorized Licensees are prohibited from disclosing any information contained in the HIN Database to any other individual, association, firm, parent or subsidiary organization that is […]

by in Uncategorized

EC Publishes EUDAMED Implementation Timeline

The European Commission (EC) published a timeline with targeted dates for the complete implementation of  EUDAMED. Currently, three of the six EUDAMED modules are available for voluntary use (the Actor Registration, UDI/Device Registration, and Notified Bodies and Certificates Modules).  The EC projects that EUDAMED will be fully functional by Q2 2023; and at that time […]